Načítá se...
Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine
BACKGROUND: Medications development efforts for methamphetamine-use disorder have targeted central monoamines because these systems are directly involved in the effects of methamphetamine. Buspirone is a dopamine autoreceptor and D3 receptor antagonist and partial agonist at serotonin 1A receptors,...
Uloženo v:
| Vydáno v: | Drug Alcohol Depend |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5683915/ https://ncbi.nlm.nih.gov/pubmed/29028556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2017.08.038 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|